Identification of Novel Markers for the Diagnosis of Malignant Pleural Mesothelioma

Fabien Gueugnon, Sabrina Leclercq, Christophe Blanquart, +6

American Journal Of Pathology

Malignant Pleural MesotheliomaSurgical PathologyDiagnosisPathologyNovel Markers +4

The oncomiR miR-197 is a novel prognostic indicator for non-small cell lung cancer patients

Konstantinos Mavridis, Fabien Gueugnon, A Petit, +4

British Journal of Cancer

Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis

Emilie Dalloneau, Nadine Baroukh, Konstantinos Mavridis, +13

Oncotarget

Neutrophil proteases alter the interleukin-22-receptor-dependent lung antimicrobial defence

Antoine Guillon, Youenn Jouan, Déborah Bréa, +11

European Respiratory Journal

Nanoparticles Produced by Ring-Opening Metathesis Polymerization Using Norbornenyl-poly(ethylene oxide) as a Ligand-Free Generic Platform for Highly Selective In Vivo Tumor Targeting

Fabien Gueugnon, Iza Denis, Daniel Pouliquen, +6

Biomacromolecules

NanoparticlesEngineeringBiomedical EngineeringTumor BiologyNanomedicine +14

CCL2, Galectin-3, and SMRP Combination Improves the Diagnosis of Mesothelioma in Pleural Effusions

Christophe Blanquart, Fabien Gueugnon, Jean‐Michel Nguyen, +6

Journal of Thoracic Oncology

Pleural EffusionsSmrp CombinationSurgical PathologyPathologyPleural Effusion +4

A 5-aza-2′-deoxycytidine/valproate combination induces cytotoxic T-cell response against mesothelioma

Sharon LeClercq, Fabien Gueugnon, Bernard Boutin, +7

European Respiratory Journal

Vorinostat–Polymer Conjugate Nanoparticles for Acid-Responsive Delivery and Passive Tumor Targeting

Iza Denis, Fatima El Bahhaj, Floraine Collette, +8

Biomacromolecules

NanoparticlesEngineeringVivo Histone DeacetylaseBiomedical EngineeringTumor Biology +16

High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4+ and CD8+ T-Cell Epitopes

Fanny Onodi, Chahrazed Maherzi-Mechalikh, Alice Mougel, +13

Frontiers in Oncology

New histone deacetylase inhibitors improve cisplatin antitumor properties against thoracic cancer cells

Fabien Gueugnon, Pierre‐François Cartron, Cédric Charrier, +4

Oncotarget